Dana Parker, MD
Anesthesiology · Houston, TXNPI 1093031734
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,326 of the $3,432 with a category attached, or 67.8%. AbbVie accounts for 74.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $2,010 and has fallen 71.7% since, to $569 in 2025. Among anesthesiology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $143.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Pacira Pharmaceuticals Incorporated$658
- Edwards Lifesciences$139
- BD$35
- Merck$19
- Astellas Pharma US Inc$19
- plus $18 from 1 others
What the payments were for
- Speaking & faculty fees$2,32668%
- Travel & lodging$54016%
- Food & beverage$56616%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $2,544 |
| Pacira Pharmaceuticals Incorporated | 5 | $658 |
| Edwards Lifesciences | 2 | $139 |
| BD | 1 | $35 |
| Merck | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Merz North America, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$540
- BOTOX$148
- HemoSphere$115
How this compares
$3,432 in reported general payments places this provider in the 95th percentile of 3,899 anesthesiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Houston
- Tong GanHouston$700K
- Gabriel MenaHouston$494K
- Harold MinkowitzHouston$224K
- Eric ChanHouston$128K
- John ZakiHouston$109K
- Jamal HasoonHouston$56K
- Barbara OrlandoHouston$42K
- Byron BakerHouston$41K
- Javier LasalaHouston$17K
- Airat AgbetobaHouston$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.